Search Browse Earnings

Anika Therapeutics, Inc. — SlamSEC

Anika Therapeutics, Inc.

Nasdaq:ANIK

Surgical & Medical Instruments & Apparatus·BEDFORD, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$120.8M

+6.1% YoY

FY 2025

Adj. EBITDA

$4.2M

3.4% margin

FY 2025

Net Income

-$82.7M

-68.4% margin

FY 2025

EPS (Diluted)

-$5.64

FY 2025

Stock Price

$14.45

+2.3%

2026-03-10

52W Range

$7.87 – $17.14

P/E Ratio

-2.6x

Market Cap

$193.6M

Cash

$55.6M

FY 2025

Total Debt

$8.0M

FY 2013

Net Cash

$47.6M

FY 2013

Enterprise Value

$145.9M

Debt / EBITDA

-11.4x

FY 2025

EV / EBITDA

35.0x

Employees

—